Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: Growth rate and optimal interval time for imaging follow-up

Journal of Computer Assisted Tomography

Volumn 36, Issue 1, 2012, Pages 20-25

  Furlan, Alessandro ^a   Marin, Daniele ^b,c   Agnello, Francesco ^d   Di Martino, Michele ^c   Di Marco, Vito ^d   Lagalla, Roberto ^d   Catalano, Carlo ^c   Brancatelli, Giuseppe ^d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

CT; Follow up; MRI; Small hepatocellular carcinoma

Indexed keywords

COMPUTERIZED TOMOGRAPHY; MAGNETIC RESONANCE IMAGING;

CONTRAST-ENHANCED; CT; DOUBLING TIME; FOLLOW UP; GADOLINIA; HEPATOCELLULAR CARCINOMA; INTERVAL TIME; MULTIDETECTOR ROW COMPUTED TOMOGRAPHY; SMALL HEPATOCELLULAR CARCINOMA; TUMOR VOLUMES;

TUMORS;

GADOLINIUM;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SIZE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; FOLLOW UP; GROWTH RATE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84856287729     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e31823ed462     Document Type: Article

References (21)

1. El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752-1763. (Pubitemid 351615415)
2. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699. (Pubitemid 26079803)
3. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236. (Pubitemid 43112690)
4. Luca A, Caruso S, Milazzo M, et al. Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants. Eur Radiol. 2010;20:898-907.
5. Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005;42:27-34. (Pubitemid 40911308)
6. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47:97-104. (Pubitemid 351171046)
7. Sangiovanni A, Manini MA, Iavarone M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut. 2010;59:638-644.
8. Jeong YY, Mitchell DG, Kamishima T. Small (G20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol. 2002;178:1327-1334. (Pubitemid 34547809)
9. O'Malley ME, Takayama Y, Sherman M. Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease. Am J Gastroenterol. 2005;100:1523-1528. (Pubitemid 41032357)
10. Takayasu K, Muramatsu Y, Mizuguchi Y, et al. CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease. AJR Am J Roentgenol. 2006;187:454-463. (Pubitemid 44148290)
11. Chung JJ, Yu JS, Kim JH, et al. Nonhypervascular hypoattenuating nodules depicted on either portal or equilibrium phase multiphasic CT images in the cirrhotic liver. AJR Am J Roentgenol. 2008;191:207-214.
12. Ebara M, Hatano R, Fukuda H, et al. Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients. Hepatogastroenterology. 1998;45(suppl 3):1214-1220. (Pubitemid 28372102)
13. Saito Y, Matsuzaki Y, Doi M, et al. Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: the MIB-1 labeling index is the most effective parameter. J Gastroenterol. 1998;33:229-235. (Pubitemid 28143402)
14. Kubota K, Ina H, Okada Y, et al. Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci. 2003;48:581-586. (Pubitemid 36324168)
15. Taouli B, Goh JS, Lu Y, et al. Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging. J Comput Assist Tomogr. 2005;29:425-429. (Pubitemid 41060272)
16. Choi D, Mitchell DG, Verma SK, et al. Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment-initial observations. Radiology. 2007;244:776-783. (Pubitemid 47292088)
17. Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med. 1956;76:988-1000.
18. Schwartz M. A biomathematical approach to clinical tumor growth. Cancer. 1961;14:1272-1294.
19. Saitoh S, Ikeda K, Koida I, et al. Serial hemodynamic measurements in well-differentiated hepatocellular carcinomas. Hepatology. 1995;21:1530-1534.
20. Holland AE, Hecht EM, Hahn WY, et al. Importance of small (G or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology. 2005;237:938-944. (Pubitemid 41636384)
21. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-1022.